How to Lose Weight on Your Tummy: UK Guide

How to lose weight on your tummy is one of the most common health questions in the UK, and for good reason. Excess abdominal fat, particularly the deeper visceral kind, is linked to serious conditions including type 2 diabetes and cardiovascular disease. Yet despite the abundance of advice online, many approaches lack clinical evidence. This article explains why tummy fat accumulates, what the research actually supports, how diet and exercise contribute, and when it is worth speaking to a GP or considering clinical weight management options.

Why do people carry extra weight around their tummy?

Abdominal fat accumulates due to a combination of genetics, hormones, age and lifestyle factors including chronic stress, poor sleep and alcohol intake, with elevated cortisol and declining oestrogen particularly associated with visceral fat deposition.

People carry extra weight around their tummy due to a combination of genetics, hormones, lifestyle habits and age. Fat is stored in two distinct layers in the abdominal area: subcutaneous fat, which sits just beneath the skin and can be pinched, and visceral fat, which lies deeper and surrounds the internal organs. It is visceral fat that tends to drive the characteristic 'apple-shaped' body profile and is more metabolically active than fat stored elsewhere.

Several factors influence where the body preferentially stores fat. Elevated levels of the stress hormone cortisol are associated with increased visceral fat accumulation, which is why chronic stress and poor sleep may contribute to a growing waistline even without significant changes in diet.^[30][31] Hormonal shifts, particularly the decline in oestrogen during the menopause, are associated with a shift in fat distribution from the hips and thighs towards the abdomen in many women.^[15][16]

Genetics also play a meaningful role. Some people are predisposed to store fat centrally, regardless of their overall body weight. Age compounds this tendency, as muscle mass naturally declines over time, slowing the metabolic rate and making it easier to accumulate abdominal fat. Regular alcohol consumption is a well-recognised contributor, as alcoholic drinks provide excess calories and are associated with greater fat storage around the middle.

Understanding these underlying drivers is important because it helps explain why targeted abdominal exercises alone are unlikely to produce significant results. Effective management of tummy fat requires addressing the broader physiological and lifestyle factors that cause it to accumulate in the first place.

Is belly fat actually bad for your health?

Visceral fat is genuinely harmful, releasing inflammatory chemicals that drive insulin resistance, raised blood glucose and elevated triglycerides, and is an independent risk factor for type 2 diabetes, cardiovascular disease and certain cancers.

Excess belly fat, particularly visceral fat, is genuinely harmful to health and is associated with a significantly increased risk of several serious conditions. Unlike subcutaneous fat, visceral fat is metabolically active and releases inflammatory chemicals and fatty acids into the portal circulation, which supplies the liver. This process is associated with insulin resistance, raised blood glucose, elevated triglycerides and unfavourable cholesterol profiles.

NHS guidance and NICE clinical guidelines consistently identify central obesity as an independent risk factor for type 2 diabetes, cardiovascular disease, metabolic dysfunction-associated steatotic liver disease (formerly known as non-alcoholic fatty liver disease) and certain cancers, including colorectal cancer and postmenopausal breast cancer, according to Cancer Research UK.^[5][7]

Waist circumference is used clinically as a practical proxy for visceral fat burden. NICE guidance indicates that a waist measurement above 88 cm (35 inches) in women and above 102 cm (40 inches) in men is associated with substantially increased health risk, though lower thresholds apply to people of South Asian, Chinese, Japanese and other ethnic backgrounds.^[5][14] NICE also recommends using waist-to-height ratio as a complementary measure: a ratio of 0.5 or above indicates increased cardiometabolic risk and has the advantage of accounting for differences in height and body frame. To calculate it, divide your waist measurement in centimetres by your height in centimetres.

It is worth noting that a person can have a body mass index (BMI) within the 'healthy' range and still carry a clinically significant amount of visceral fat, a pattern sometimes described as 'metabolically obese, normal weight'. Conversely, someone with a higher BMI who carries fat predominantly on the hips and thighs may face a lower cardiometabolic risk than their weight alone would suggest.

The reassuring finding from research is that visceral fat tends to respond relatively well to lifestyle intervention. Even modest reductions in overall body weight, in the region of 5 to 10 per cent, can produce meaningful reductions in visceral fat and measurable improvements in metabolic markers, according to evidence reviewed by NICE.^[5][19]

What really works for losing weight around your middle?

A moderate calorie deficit combined with regular aerobic and resistance exercise is the most robustly evidenced approach, with NICE-recommended pharmacological options such as semaglutide or tirzepatide available for eligible adults who have not achieved results through lifestyle change alone.

Losing weight around the middle requires a sustained reduction in overall body fat through a combination of dietary change, increased physical activity and, where appropriate, clinical support. There is no evidence that any food, supplement or exercise can selectively remove fat from the abdomen, a concept sometimes called 'spot reduction'. When the body loses fat, it does so systemically, and the abdomen is simply one of the areas from which fat is drawn.

The most robustly evidenced approach combines a moderate calorie deficit with regular aerobic exercise and resistance training. Behavioural strategies, including structured meal planning, mindful eating and adequate sleep, support adherence and may help manage cortisol levels, which are associated with visceral fat accumulation. Reducing alcohol intake is also a practical and often underestimated step.

For people with obesity or weight-related health conditions who have not achieved sufficient results through lifestyle change alone, NICE-recommended weight management programmes and, in some cases, pharmacological treatment may be appropriate. Medicines such as semaglutide (Wegovy) and tirzepatide (Mounjaro) are both MHRA-authorised in the UK for chronic weight management and have demonstrated clinically significant reductions in body weight and waist circumference in large randomised trials, including the STEP and SURMOUNT trial programmes respectively.^[1][2] Both have received NICE technology appraisal recommendations supporting their use within NHS weight management pathways, subject to eligibility criteria.^[2][3] Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight management consultations, with prescriber review and pharmacist support, where a prescriber may consider these options if they are clinically appropriate.

Setting realistic expectations is important. Sustainable fat loss is typically measured in months rather than weeks, and approaches that promise rapid abdominal results are rarely supported by robust clinical evidence.

How does diet affect tummy fat specifically?

High intakes of ultra-processed foods, refined carbohydrates and sugar-sweetened drinks are associated with greater visceral fat, while diets rich in fibre, protein and unsaturated fats, such as a Mediterranean-style pattern, are linked to lower abdominal fat and reduced cardiometabolic risk.

Diet has a direct and well-evidenced effect on abdominal fat, both through overall calorie balance and through the specific types of food consumed. A consistent calorie surplus, regardless of its source, leads to fat storage, and the abdomen is a common site for this accumulation. However, the composition of the diet also matters independently of total calories.

High intakes of ultra-processed foods, refined carbohydrates and added sugars are associated with greater visceral fat accumulation.^[30][31] These foods promote rapid rises in blood glucose and insulin, which in turn are associated with fat storage around the organs. Sugar-sweetened drinks are particularly implicated, as liquid calories are less satiating and the free sugars they contain, including fructose from added sugars, are associated with greater hepatic fat synthesis.

By contrast, diets rich in:

• Fibre (vegetables, legumes, wholegrains and fruit) support satiety and a healthy gut microbiome, both of which are linked to lower visceral fat

• Protein (lean meat, fish, eggs, dairy and plant sources) helps preserve muscle mass during weight loss and increases feelings of fullness

• Unsaturated fats (olive oil, nuts, avocado and oily fish) are associated with more favourable fat distribution compared with diets high in saturated fat

Mediterranean-style dietary patterns have been studied extensively and are associated with lower visceral fat and reduced cardiometabolic risk.^[18] The NHS Eatwell Guide provides a practical framework for achieving a balanced diet in line with UK recommendations. Reducing alcohol is equally important, as it contributes excess calories and is associated with central fat deposition. No single 'superfood' or elimination diet has been shown to target tummy fat specifically, and extreme restriction is rarely sustainable.

Can exercise help you lose weight on your tummy?

Aerobic exercise reduces visceral fat more effectively than subcutaneous fat, and combining it with resistance training produces better outcomes than either approach alone, though abdominal exercises alone cannot selectively burn tummy fat.

Exercise is one of the most effective tools for reducing visceral fat, even when overall body weight changes only modestly. Research consistently shows that aerobic exercise, such as brisk walking, cycling, swimming and jogging, reduces visceral fat more effectively than subcutaneous fat, making it particularly valuable for improving abdominal health.^[20][21] The UK Chief Medical Officers' physical activity guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week for adults, alongside muscle-strengthening activities on two or more days.^[8][9] These guidelines are reflected in NHS advice on physical activity for adults.

Resistance training, including weight lifting and bodyweight exercises, complements aerobic activity by preserving and building muscle mass. Greater muscle mass raises the resting metabolic rate, meaning the body burns more calories at rest, which supports long-term fat management. A combination of both aerobic and resistance exercise produces better outcomes for visceral fat reduction than either approach alone.

Abdominal exercises such as crunches, planks and sit-ups strengthen and tone the core muscles, which can improve posture and functional fitness. However, they do not selectively burn the fat overlying those muscles. Visible abdominal definition is primarily a consequence of overall body fat reduction rather than the volume of core work performed.

High-intensity interval training (HIIT), which alternates short bursts of intense effort with recovery periods, has shown promise for visceral fat reduction in several studies and may be time-efficient for people with busy schedules.^[22][24] If you have an existing cardiovascular, metabolic or musculoskeletal condition, it is advisable to start any new exercise programme gradually and to seek advice from a healthcare professional before beginning higher-intensity activity. That said, any form of regular movement is beneficial, and the best exercise is one that can be maintained consistently over time. Reducing prolonged sitting, even by taking short walks throughout the day, also contributes meaningfully to metabolic health and abdominal fat management.

When should you speak to a GP about your weight?

You should speak to a GP if excess weight is affecting your health, if lifestyle changes have not produced results, or if you have a waist circumference above NICE thresholds, rapid unexplained weight gain, or symptoms suggesting a weight-related complication.

Speaking to a GP about weight is appropriate when excess weight is affecting health, wellbeing or quality of life, or when lifestyle changes alone have not produced meaningful results over a sustained period. A GP can assess whether weight-related health conditions such as type 2 diabetes, high blood pressure, sleep apnoea or joint problems are present or developing, and can refer to structured NHS weight management services where eligible.

There are specific circumstances in which seeking a GP appointment promptly is advisable:

• Rapid, unexplained weight gain around the abdomen, particularly if accompanied by fatigue, mood changes or changes in body hair, which may suggest an underlying hormonal condition such as hypothyroidism or Cushing's syndrome

• A waist circumference above the thresholds recommended by NICE (88 cm in women, 102 cm in men, or lower thresholds for South Asian and other at-risk ethnic groups), or a waist-to-height ratio of 0.5 or above, alongside other risk factors such as raised blood pressure or a family history of diabetes

• Difficulty losing weight despite consistent effort, which may warrant investigation of metabolic or hormonal factors, or a review of any medicines you are taking, as some long-term treatments such as corticosteroids can contribute to central weight gain

• Symptoms that may indicate a weight-related complication, such as breathlessness, chest discomfort, or significant joint pain

For urgent symptoms such as severe chest pain or sudden breathlessness, call 999 immediately. For non-emergency health concerns that cannot wait for a GP appointment, NHS 111 can provide advice.

GPs can also discuss whether pharmacological treatment is appropriate and, where relevant, refer to specialist weight management services. NICE technology appraisals have recommended certain medicines for use within NHS pathways, though local Integrated Care Boards (ICBs) make commissioning decisions about which treatments are available in their area. Seeking professional guidance early is always preferable to waiting until health complications have developed.

Scientific References

1. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
2. Tirzepatide | Drugs | BNF - NICE.
3. Semaglutide | Drugs - BNF - NICE.
4. Wegovy | European Medicines Agency (EMA).
5. Overweight and obesity management – Identifying and assessing overweight, obesity and central adiposity (NG246).
6. Appendix A1: Summary of evidence from surveillance (NG246) – BMI cut-off points for South Asian and Chinese populations.
7. Cardiovascular disease: risk assessment and reduction (NG238).
8. Physical activity guidelines: UK Chief Medical Officers' report.
9. UK Chief Medical Officers' physical activity guidelines (full report).
10. Physical activity guidelines for adults aged 19 to 64.
11. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
12. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1).
13. Indirect comparative efficacy and safety of tirzepatide versus semaglutide for obesity in type 2 diabetes (SURMOUNT-2 and STEP 2).
14. Waist circumference as a measure for indicating need for weight management (Lean et al.).
15. Adipose Tissue Sex Steroids in Postmenopausal Women With and Without Menopausal Hormone Therapy.
16. Associations between abdominal adipose tissue, reproductive span, and brain characteristics in post-menopausal women.
17. Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan.
18. Effects of the Mediterranean Diet on the Components of Metabolic Syndrome (Scaglione et al.).
19. Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health: MRI-Assessed 5- and 10-Year Follow-Up (CENTRAL and DIRECT-PLUS trials).
20. A dose-response relation between aerobic exercise and visceral fat reduction (Ohkawara et al.).
21. Aerobic Exercise and Weight Loss in Adults: A Systematic Review (Jayedi et al.).
22. Effect of High-Intensity Interval Training on Total, Abdominal and Visceral Fat Mass (Maillard et al.).
23. Comparative Efficacy of Exercise Type on Visceral Adipose Tissue in Patients With Prediabetes and Type 2 Diabetes: Systematic Review with Meta-Analyses.
24. Effect of low-volume interval training on whole-body, abdominal and visceral fat: Systematic review and meta-analysis.
25. Efficacy of Interval Training in Improving Body Composition and Adiposity in Apparently Healthy Adults: Umbrella Review with Meta-Analysis.
26. Waist-to-Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity.
27. Sugar-Sweetened Beverages and Childhood Obesity: A Life-Course Perspective.
28. Metabolic benefits of ketohexokinase inhibition in individuals with MASLD: fructose metabolism and cardiometabolic disease.
29. The association between high fructose corn syrup and the development of type-2 diabetes.
30. Is visceral obesity a physiological adaptation to stress?.
31. Stress-induced cortisol response and fat distribution (Moyer et al.).

Frequently Asked Questions